Showing results (111-120 of 413) with videos related to

Sort By:
Pageof 42
Gynecologic Oncology Reports|October 2, 2015
The problem of late ovarian metastases from primary cervical adenocarcinomaKatie A Ashton, James Scurry, Sepehr N Tabrizi, et al.
Journal of Medical Microbiology|August 25, 2021
The effect of probiotic supplementation on the gut microbiota of preterm infantsErica L Plummer, Jennifer A Danielewski, Suzanne M Garland, et al.
Sexual Health|December 20, 2020
Quadrivalent human papillomavirus vaccination successfully reduces the prevalence of vaccine-targeted genotypes in a young, vaccine-eligible-age sample of Australian femalesAsvini K Subasinghe, John D Wark, Samuel Phillips, et al.
Journal of Lower Genital Tract Disease|April 20, 2016
Can Routine Histopathology Distinguish Between Vulvar Cutaneous Candidosis and Dermatophytosis?Tania Day, Ailsa Borbolla Foster, Samuel Phillips, et al.
Journal of Clinical Microbiology|June 1, 2012
Comparison of PapType to Digene Hybrid Capture 2, Roche linear array, and Amplicor for detection of high-risk human papillomavirus genotypes in women with previous abnormal pap smearsSepehr N Tabrizi, Matthew P Stevens, Zaheer A Khan, et al.
JNCI Cancer Spectrum|March 22, 2021
Human Papillomavirus Vaccination After COVID-19Zheng Quan Toh, Fiona M Russell, Suzanne M Garland, et al.
BMC Infectious Diseases|December 11, 2012
The prevalence of anal human papillomavirus among young HIV negative men who have sex with menHuachun Zou, Christopher K Fairley, Jane S Hocking, et al.
Journal of Health Economics and Outcomes Research|October 22, 2020
Estimating the Burden of Illness Related to Genital Warts in Russia: A Cross-Sectional StudyVera N Prilepskaya, Mikhail Gomberg, Smita Kothari, et al.
Letters in Applied Microbiology|October 26, 2023
Evaluation of TIB Molbiol LightMix® assays for detection of Mycoplasma genitalium and key resistance mutations for macrolides and fluoroquinolonesPrisha Balgovind, Steph Atchison, Jennifer Danielewski, et al.
Infection and Drug Resistance|July 17, 2019
Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirusZheng Quan Toh, Jennie Kosasih, Fiona M Russell, et al.
Pageof 42